Author Rights and Data Ownership

Authors retain ownership of all research data. We encourage authors to deposit datasets, protocols, and supplementary files in trusted repositories and allow the journal to link to these resources from the published article. This improves transparency and enables reuse by the AMR community.

When data cannot be fully shared due to legal, ethical, or commercial constraints, authors should provide a clear data availability statement describing limitations and how qualified researchers can request access.

What to Archive

Archive materials that support replication, validation, and future research applications.

Data Availability Statement

Every manuscript must include a data availability statement that identifies repositories, accession numbers, or access restrictions. For pathogen genomics or surveillance work, provide database names and identifiers to ensure reliable access.

Sensitive Data and Controlled Access

We balance openness with patient privacy, biosafety requirements, and legal constraints. If data contain identifiable patient information or sensitive laboratory details, de-identify records and provide controlled access where appropriate.

Permissions Granted to the Journal

By publishing with us, authors grant permission for the journal to link datasets, display data availability statements, and host supplementary files alongside the article. These permissions do not transfer ownership and are intended solely to improve transparency and access for readers.

Repository Best Practices

Choose repositories that provide persistent identifiers and long-term preservation. Include a README describing file formats, units, and any processing steps. For genomic data, provide accession numbers and reference genome details so readers can interpret findings correctly.

Embargoes and Controlled Access

If data must remain under embargo or controlled access, explain the reason and expected release date. Provide a contact pathway for qualified access and document any biosafety or privacy constraints. Transparent restrictions preserve trust while protecting sensitive information.

Data Citation and Credit

Cite datasets in the reference list using repository-provided DOIs or accession numbers. Data citation increases the visibility of underlying resources and ensures proper credit to research teams and institutions.

Author Responsibilities

Authors are responsible for confirming that shared data are accurate, legally permissible, and aligned with consent or biosafety requirements. The journal may request clarification or additional metadata if needed to support reproducibility.

Recommended AMR Data Elements

Whenever possible, include isolate identifiers, collection dates, geographic context, antimicrobial panels tested, and interpretive criteria. These details improve comparability across studies and support regional or global surveillance efforts.

Access Upon Request

If data cannot be shared openly, provide a clear statement describing the request process, eligibility, and expected response time. This transparency allows reviewers and readers to understand how evidence can be verified.

Clinical Data Anonymization

Remove direct identifiers and apply accepted anonymization techniques before sharing clinical datasets. Describe anonymization steps in the data availability statement to support ethical transparency.

Repository Selection Guidance

Select repositories that provide persistent identifiers and long term access. If sensitive data require controlled access, explain the restrictions and provide a contact point for qualified requests. Metadata should be sufficient to locate, interpret, and reuse archived datasets responsibly.